What is he best known for?
The fields of study he is best known for:
Robert H. Shoemaker focuses on Cell culture, Cancer research, In vitro, Cancer and Molecular biology.
Human tumor is closely connected to Cell growth in his research, which is encompassed under the umbrella topic of Cell culture.
His Cancer research study integrates concerns from other disciplines, such as HIV Protease Inhibitor, Drug resistance and In vivo.
The study incorporates disciplines such as Virus, Virology, Thiazole and Pathology in addition to In vitro.
His work focuses on many connections between Cancer and other disciplines, such as Pharmacology, that overlap with his field of interest in Melanoma, Cancer chemotherapy and Tumor cells.
Robert H. Shoemaker works mostly in the field of Molecular biology, limiting it down to concerns involving Sulforhodamine B and, occasionally, Immunology, IC50, Growth inhibition, MTT assay and Staining.
His most cited work include:
- Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay (2704 citations)
- Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines (2476 citations)
- Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines (2057 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cancer research, Cancer, Cell culture, Biochemistry and Molecular biology.
Robert H. Shoemaker works mostly in the field of Cancer research, limiting it down to topics relating to Pathology and, in certain cases, Transplantation.
His Cancer research is multidisciplinary, relying on both Pre-clinical development, Immunology, Oncology and Pharmacology.
His research on Cell culture frequently connects to adjacent areas such as In vitro.
His research investigates the connection with In vitro and areas like Stereochemistry which intersect with concerns in Biological activity and Cytotoxic T cell.
Robert H. Shoemaker has researched Molecular biology in several fields, including Gene expression and Recombinant DNA.
He most often published in these fields:
- Cancer research (34.96%)
- Cancer (21.14%)
- Cell culture (17.89%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (34.96%)
- Cancer (21.14%)
- Internal medicine (8.94%)
In recent papers he was focusing on the following fields of study:
Robert H. Shoemaker spends much of his time researching Cancer research, Cancer, Internal medicine, Oncology and Immune system.
His Cancer research research incorporates elements of Plasma cell, T cell, KRAS, Estrogen receptor and ROS1.
Within one scientific family, Robert H. Shoemaker focuses on topics pertaining to Gene rearrangement under ROS1, and may sometimes address concerns connected to Molecular biology, Nucleic acid and Immunohistochemistry.
The Cancer study combines topics in areas such as Lung cancer, Medicinal chemistry and Peptide vaccine.
His Oncology research includes elements of Animal model, Pre-clinical development, Biomarker and Survival rate.
His research investigates the connection between Immune system and topics such as Antigen that intersect with problems in Antibody, Cancer immunoprevention, In vitro and Biochemistry.
Between 2016 and 2021, his most popular works were:
- ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer. (140 citations)
- Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment Followed by Sensitive Next-Generation Sequencing. (45 citations)
- Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine (11 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Cancer, Cancer research, Vaccination, Internal medicine and Oncology.
Cancer is often connected to Peptide vaccine in his work.
His Cancer research research focuses on subjects like T cell, which are linked to Plasmablastic lymphoma, Primary effusion lymphoma, Nucleoside and Lymphoma.
His Vaccination research also works with subjects such as
- Antigen which connect with Pseudovirion, Immune Targeting, Cancer immunoprevention, Immunotherapy and Neutralizing antibody,
- Adjuvant, which have a strong connection to Virology, Immunogenicity, Humoral immunity and Epitope.
He is interested in Colorectal cancer, which is a branch of Internal medicine.
Robert H. Shoemaker interconnects Survival rate, ROS1, Primary tumor and Clinical trial in the investigation of issues within Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
